Jose L Cantero1, Juan E Iglesias2, Koen Van Leemput3, Mercedes Atienza4. 1. Laboratory of Functional Neuroscience, CIBERNED (Network Center for Biomedical Research in Neurodegenerative Diseases), Pablo de Olavide University, Seville, Spain. jlcanlor@upo.es. 2. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston. Basque Center on Cognition, Brain and Language, San Sebastian, Spain. 3. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston. Department of Applied Mathematics and Computer Science, Technical University of Denmark, Lyngby, Denmark. 4. Laboratory of Functional Neuroscience, CIBERNED (Network Center for Biomedical Research in Neurodegenerative Diseases), Pablo de Olavide University, Seville, Spain.
Abstract
BACKGROUND: Evidence suggests a link between the presence of subjective memory complaints (SMC) and lower volume of the hippocampus, one of the first regions to show neuropathological lesions in Alzheimer's disease. However, it remains unknown whether this pattern of hippocampal atrophy is regionally specific and whether SMC are also paralleled by changes in peripheral levels of amyloid-beta (Aβ). METHODS: The volume of hippocampal subregions and plasma Aβ levels were cross-sectionally compared between elderly individuals with (SMC(+); N = 47) and without SMC (SMC(-); N = 48). Significant volume differences in hippocampal subregions were further correlated with plasma Aβ levels and with objective memory performance. RESULTS: Individuals with SMC exhibited significantly higher Aβ1-42 concentrations and lower volumes of CA1, CA4, dentate gyrus, and molecular layer compared with SMC(-) participants. Regression analyses further showed significant associations between lower volume of the dentate gyrus and both poorer memory performance and higher plasma Aβ1-42 levels in SMC(+) participants. CONCLUSIONS: The presence of SMC, lower volumes of specific hippocampal regions, and higher plasma Aβ1-42 levels could be conditions associated with aging vulnerability. If such associations are confirmed in longitudinal studies, the combination may be markers recommending clinical follow-up in nondemented older adults.
BACKGROUND: Evidence suggests a link between the presence of subjective memory complaints (SMC) and lower volume of the hippocampus, one of the first regions to show neuropathological lesions in Alzheimer's disease. However, it remains unknown whether this pattern of hippocampal atrophy is regionally specific and whether SMC are also paralleled by changes in peripheral levels of amyloid-beta (Aβ). METHODS: The volume of hippocampal subregions and plasma Aβ levels were cross-sectionally compared between elderly individuals with (SMC(+); N = 47) and without SMC (SMC(-); N = 48). Significant volume differences in hippocampal subregions were further correlated with plasma Aβ levels and with objective memory performance. RESULTS: Individuals with SMC exhibited significantly higher Aβ1-42 concentrations and lower volumes of CA1, CA4, dentate gyrus, and molecular layer compared with SMC(-) participants. Regression analyses further showed significant associations between lower volume of the dentate gyrus and both poorer memory performance and higher plasma Aβ1-42 levels in SMC(+) participants. CONCLUSIONS: The presence of SMC, lower volumes of specific hippocampal regions, and higher plasma Aβ1-42 levels could be conditions associated with aging vulnerability. If such associations are confirmed in longitudinal studies, the combination may be markers recommending clinical follow-up in nondemented older adults.
Authors: Nicolas Villain; Gaël Chételat; Blandine Grassiot; Pierrick Bourgeat; Gareth Jones; Kathryn A Ellis; David Ames; Ralph N Martins; Francis Eustache; Olivier Salvado; Colin L Masters; Christopher C Rowe; Victor L Villemagne Journal: Brain Date: 2012-05-23 Impact factor: 13.501
Authors: Liana G Apostolova; Rebecca A Dutton; Ivo D Dinov; Kiralee M Hayashi; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson Journal: Arch Neurol Date: 2006-05
Authors: M J de Leon; J Golomb; A E George; A Convit; C Y Tarshish; T McRae; S De Santi; G Smith; S H Ferris; M Noz Journal: AJNR Am J Neuroradiol Date: 1993 Jul-Aug Impact factor: 3.825
Authors: A J Saykin; H A Wishart; L A Rabin; R B Santulli; L A Flashman; J D West; T L McHugh; A C Mamourian Journal: Neurology Date: 2006-09-12 Impact factor: 9.910
Authors: Kirsty L Spalding; Olaf Bergmann; Kanar Alkass; Samuel Bernard; Mehran Salehpour; Hagen B Huttner; Emil Boström; Isabelle Westerlund; Celine Vial; Bruce A Buchholz; Göran Possnert; Deborah C Mash; Henrik Druid; Jonas Frisén Journal: Cell Date: 2013-06-06 Impact factor: 41.582
Authors: Dustin R Masser; Georgina V Bixler; Robert M Brucklacher; Han Yan; Cory B Giles; Jonathan D Wren; William E Sonntag; Willard M Freeman Journal: J Gerontol A Biol Sci Med Sci Date: 2014-07-02 Impact factor: 6.053
Authors: N Ertekin-Taner; L H Younkin; D M Yager; F Parfitt; M C Baker; S Asthana; M L Hutton; S G Younkin; N R Graff-Radford Journal: Neurology Date: 2007-10-03 Impact factor: 9.910
Authors: Marcos A Marques; J Jacob Kulstad; Christopher E Savard; Pattie S Green; Sum P Lee; Suzanne Craft; G Stennis Watson; David G Cook Journal: J Alzheimers Dis Date: 2009 Impact factor: 4.472
Authors: Zvinka Z Zlatar; Martha C Muniz; Sarah G Espinoza; Roberto Gratianne; Tamar H Gollan; Douglas Galasko; David P Salmon Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Young Min Choe; Guk-Hee Suh; Boung Chul Lee; Ihn-Geun Choi; Jun Ho Lee; Hyun Soo Kim; Jaeuk Hwang; Jee Wook Kim Journal: Front Neurosci Date: 2022-07-04 Impact factor: 5.152
Authors: Shannon M Drouin; G Peggy McFall; Olivier Potvin; Pierre Bellec; Mario Masellis; Simon Duchesne; Roger A Dixon Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160